PDA PAC iAM 2017 Survey on Post Approval Change: Is the Regulatory Environment Hindering Much-Needed Innovation in the Pharma Industry?
Authors: Members of the PDA Task Force Post Approval Changes for Innovation in Availability of Medicines (PAC iAM); Ramnarine E, Busse U, Colao M, Edwards J, Follman K, Gale K, Good K, Kiani S, Jornitz M, Munk M, O'Donnel K, Seymour M, Simianu M, Skeens L, Vinther A, Baker D, Levy R.
Authors: Members of the PDA Task Force Post Approval Changes for Innovation in Availability of Medicines (PAC iAM), et al. Among authors: ramnarine e.
PDA J Pharm Sci Technol. 2017 Sep-Oct;71(5):421-427. doi: 10.5731/pdajpst.2017.008219. Epub 2017 Aug 17.
PDA J Pharm Sci Technol. 2017.
PMID: 28819050
No abstract available.